These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35434055)

  • 21. Clinical vignette in antiretroviral therapy: jaundice.
    Zell SC
    J Int Assoc Physicians AIDS Care (Chic); 2003; 2(4):133-9. PubMed ID: 14986514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid therapy for a case of severe drug-induced cholestasis.
    Giannattasio A; D'Ambrosi M; Volpicelli M; Iorio R
    Ann Pharmacother; 2006 Jun; 40(6):1196-9. PubMed ID: 16720710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ticlopidine-induced cholestatic hepatitis with anti-nuclear antibody in serum.
    Tsai MH; Tsai SL; Chen TC; Liaw YF
    J Formos Med Assoc; 2000 Nov; 99(11):866-9. PubMed ID: 11155780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case report: nasobiliary drainage inducing remission in benign recurrent intrahepatic cholestasis.
    Toros AB; Ozerdenen F; Bektaş H; Sari ND
    Turk J Gastroenterol; 2012 Feb; 23(1):75-8. PubMed ID: 22505385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.
    Sarganas G; Orzechowski HD; Klimpel A; Thomae M; Kauffmann W; Herbst H; Bronder E; Garbe E
    Neuro Oncol; 2012 May; 14(5):541-6. PubMed ID: 22394496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Literature review of the clinical characteristics of metformin-induced hepatotoxicity.
    Wang C; Deng H; Xu Y; Liu Y
    Front Pharmacol; 2022; 13():969505. PubMed ID: 36147344
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe intrahepatic cholestasis caused by amiodarone toxicity after withdrawal of the drug: a case report and review of the literature.
    Chang CC; Petrelli M; Tomashefski JF; McCullough AJ
    Arch Pathol Lab Med; 1999 Mar; 123(3):251-6. PubMed ID: 10086516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prenatal exposure to methamphetamine presenting as neonatal cholestasis.
    Dahshan A
    J Clin Gastroenterol; 2009 Jan; 43(1):88-90. PubMed ID: 18633333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pantoprazole-induced autoimmune chronic hepatitis.
    Meunier L; Ursic-Bedoya J; Pageaux GP; Larrey D
    Liver Int; 2018 Jun; 38(6):995-999. PubMed ID: 29532602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe cholestatic jaundice in hyperthyroidism after treatment with 131-iodine.
    Hasan MK; Tierney WM; Baker MZ
    Am J Med Sci; 2004 Dec; 328(6):348-50. PubMed ID: 15599331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of fosinopril-induced severe cholestatic jaundice with plasma exchange.
    Chou JW; Yu CJ; Chuang PH; Lai HC; Hsu CH; Cheng KS; Peng CY; Chiang IP
    Ann Pharmacother; 2008 Dec; 42(12):1887-92. PubMed ID: 19017832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ticlopidine-induced cholestatic hepatitis.
    Skurnik YD; Tcherniak A; Edlan K; Sthoeger Z
    Ann Pharmacother; 2003 Mar; 37(3):371-5. PubMed ID: 12639165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flucloxacillin induced delayed cholestatic hepatitis.
    Miros M; Kerlin P; Walker N; Harris O
    Aust N Z J Med; 1990 Jun; 20(3):251-3. PubMed ID: 2372276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic injury associated with amineptine therapy.
    Ricca Rosellini S; Grilli F; Gaudio M; Saragoni A; Miglio F
    Ital J Gastroenterol; 1990 Feb; 22(1):40-3. PubMed ID: 2131927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pruritus of chronic cholestasis.
    Raiford DS
    QJM; 1995 Sep; 88(9):603-7. PubMed ID: 7583073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candesartan-induced cholestatic hepatitis: a case report.
    Hermida Pérez B; Izquierdo Romero M; García López R
    Rev Esp Enferm Dig; 2020 Dec; 112(12):959-960. PubMed ID: 33226250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged cholestasis after troleandomycin-induced acute hepatitis.
    Larrey D; Amouyal G; Danan G; Degott C; Pessayre D; Benhamou JP
    J Hepatol; 1987 Jun; 4(3):327-9. PubMed ID: 3496378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholestatic hepatitis as a possible new side-effect of oxycodone: a case report.
    Ho V; Stewart M; Boyd P
    J Med Case Rep; 2008 May; 2():140. PubMed ID: 18452597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute cholestatic hepatitis associated with celecoxib.
    Grieco A; Miele L; Giorgi A; Civello IM; Gasbarrini G
    Ann Pharmacother; 2002 Dec; 36(12):1887-9. PubMed ID: 12452750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.